Table 1.
A summary of ongoing classical therapies and vaccine platforms for COVID-19.
| Trial code | Intervention | Country | Phase |
|---|---|---|---|
| NCT04333550 | Daily IV deferoxamin for 3–5 days | Iran | I/II |
| NCT04333420 | Best supportive care+ IFX1 | Netherland | II/III |
| NCT04324996 | ACE-2CAR-NK/ NKG2D CARNK/ ACE2-NKG2D CAR NK/ NK /IL-15 NK injection (108 cells/kg/week) | China | I/II |
| NCT04304313 | Soldenafil citrate tablets | China | III |
| NCT04326920 | Sargramostim inhalation/IV injection | Belguim | IV |
| NCT04299724 | Pathogen specific COVID19/aAPC (5 × 106) vaccine three sub cutaneous injection | China | I |
| NCT04307693 | Lopinavir/ritonavir /Hydroxy chloroquine sulfate oral tablets (7–10 days) | China | II |
| NCT04292899 | Remdesvir IV injection | South Korea | III |
| NCT04276896 | LV-SMENP-DC (5 × 106) vaccine and antigen-specific CTLs (1 × 108)sub cutaneous injection | China | I/II |
| NCT04327206 | BCG vaccine | Australia | III |
| NCT0425484 | Abidol hydrochloride/ Interferon atomization | China | IV |
| NCT04263402 | Methylprednisolone <40 mg/d or 40-80 mg/d for 7 days (IV) | China | IV |
| NCT04315948 | Remdesivir/Lopinavir/ritonavir/ Interferon Beta-1A/Hydroxychloroquin | France | III |
| NCT04320238 | recombinant human interferon Alpha-1b drops/ thymosin alpha 1 SC injection | China | III |
| NCT03808922 | DAS181 4.5 mg | USA | III |
| NCT04330300 | Thiazide or Thiazide-like diuretic/ Calcium Channel Blockers / ACE inhibitor/ Angiotensin receptor blocker | Ireland | IV |
| NCT04283461 | mRNA-1273 vaccine | USA | I |
| NCT04405076 | mRNA-1273 (50-100μg) | USA | II |
| NCT04322682 | Colchicine 0.5 mg | Canada | III |
| NCT04252274 | Darunavir and Cobicistat | China | III |
| NCT04275245 | Meplazumab | China | I/II |
| NCT04341038 | Tacrolimus (8–10 ng/ml blood level)/ Methylprednisolone (120 mg/day) | Spain | III |
| NCT04374032 | metenkefalin + tridecactide | Bosnia and Herzegovina | II/III |
| NCT04393038 | ABX464 50 mg | France | II/III |
| NCT04335136 | RhACE2 (IV twice daily) | Austria, Denmark, Germany | II |
| NCT04380701 | BNT162a1/ BNT162b1/BNT162b2/ BNT162c2 (Anti-viral RNA vaccine), IM | Germany | II |
| NCT04388826 | Veru-111 (18 mg capsule orally) α and β tubulin inhibitor | USA | II |
| NCT04388826 | Camostat Mesilate (2 × 100 mg pills 3 times daily for 5 days) | Denmark | II |
| NCT04340557 | Losartan 12.5 mg orally twice daily for up to 10 days | USA | IV |
| NCT04334629 | Lipid Ibuprofen 200 mg | UK | IV |
I·V = intra venous, RhACE2 = Recombinant human angiotensin – converting enzyme 2, S·C = sub cutaneous.